title: Therapeutic drug monitoring during pregnancy and lactation: thyroid function assessment in pregnancy-challenges and solutions.
abstract: The diagnosis and monitoring of thyroid disease necessitates the knowledge of thyroid pathophysiology and of the technical limitations of current thyroid-related biochemical tests. Thyroid disease diagnosis and monitoring are further complicated during pregnancy and lactation, due to pregnancy-related changes in thyroid hormone metabolism. Dramatic changes that occur in thyroxine and triiodothyronine ranges during pregnancy pose challenges for hypothyroid gravidas. Very early in pregnancy, levothyroxine replacement needs to be increased. Moreover, increases in thyroid hormone replacement need to be conducted individually and on a timely basis. For reasons that are still not entirely clear, although dependent in part on changes in thyroxine binding, free thyroxine (FT4) levels decrease as pregnancy progresses necessitating the use of trimester-specific reference intervals for appropriate replacement. Thyroxine binding protein levels vary by hormonal status, inheritance, and disease states and are higher in pregnancy; hence, FT4 assays became popular because they measure the unbound hormone. However, current FT4 immunoassays are estimate tests that do not reliably measure FT4 and are known to be sensitive to alterations in binding proteins and therefore are method-specific. The need to reliably identify hypothyroxinemic pregnant patients, especially in the first trimester, is of prime importance for early fetal brain development before the fetal thyroid functions. This article addresses 1) the current limitations of laboratory-free thyroxine immunoassay methodologies and especially during pregnancy; 2) trimester-specific reference intervals for thyroid function tests; and 3) the study of levothyroxine pharmacokinetics in pregnant and nonpregnant women.
authors.affiliation: Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, USA. os35@georgetown.edu
authors.forename: Offie P
authors.initials: OP
authors.lastname: Soldin
mesh_terms: D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000097:blood; D007455:Iodine / Q000097:blood; D007774:Lactation / Q000097:blood*; D011247:Pregnancy / Q000097:blood; D011248:Pregnancy Complications / Q000097:blood*; D011264:Pregnancy Trimesters; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology; D013963:Thyroid Hormones / Q000097:blood*; D013972:Thyrotropin / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology*; D013975:Thyroxine-Binding Proteins / Q000378:metabolism; D014284:Triiodothyronine / Q000494:pharmacology*
chemical_list: D013963:Thyroid Hormones; D013975:Thyroxine-Binding Proteins; D014284:Triiodothyronine; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine
references.citation: Am J Obstet Gynecol. 2008 Jul;199(1):62.e1-6
references.pmid: 18585522
references.citation: Baillieres Clin Endocrinol Metab. 1989 Nov;3(3):627-57
references.pmid: 2698148
references.citation: N Engl J Med. 1981 Mar 19;304(12):702-12
references.pmid: 6258072
references.citation: Clin Chim Acta. 2005 Feb;352(1-2):93-104
references.pmid: 15653103
references.citation: Clin Chem. 1989 Jul;35(7):1362-6
references.pmid: 2758578
references.citation: Obstet Gynecol. 2007 May;109(5):1129-35
references.pmid: 17470594
references.citation: N Engl J Med. 1999 Aug 19;341(8):549-55
references.pmid: 10451459
references.citation: Clin Lab. 2004;50(9-10):581-4
references.pmid: 15481634
references.citation: Thyroid. 2007 Apr;17(4):303-11
references.pmid: 17465859
references.citation: Am J Obstet Gynecol. 2009 Mar;200(3):260.e1-6
references.pmid: 19114271
references.citation: Clin Chem. 2007 May;53(5):985-8
references.pmid: 17395710
references.citation: Clin Chem. 2003 Sep;49(9):1531-5
references.pmid: 12928239
references.citation: Thyroid. 2004 Jun;14(6):479-80; author reply 480-1
references.pmid: 15242581
references.citation: Ther Drug Monit. 2007 Oct;29(5):553-9
references.pmid: 17898643
references.citation: Clin Chem. 2005 Aug;51(8):1480-6
references.pmid: 15961550
references.citation: Eur J Obstet Gynecol Reprod Biol. 2008 Mar;137(1):61-6
references.pmid: 18093719
references.citation: Clin Chem Lab Med. 2003 Jul;41(7):942-7
references.pmid: 12940522
references.citation: South Med J. 1986 Jul;79(7):836-9
references.pmid: 3088731
references.citation: Thyroid. 2004 Dec;14(12):1084-90
references.pmid: 15650363
references.citation: N Engl J Med. 1994 Oct 20;331(16):1072-8
references.pmid: 8090169
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8 Suppl):S1-47
references.pmid: 17948378
references.citation: N Engl J Med. 1990 Jul 12;323(2):91-6
references.pmid: 2359428
references.citation: Am J Clin Pathol. 1997 Oct;108(4):417-21
references.pmid: 9322595
references.citation: Clin Biochem. 1992 Apr;25(2):77-87
references.pmid: 1623581
references.citation: Clin Endocrinol (Oxf). 2000 Sep;53(3):265-78
references.pmid: 10971442
references.citation: J Endocrinol Invest. 1993 May;16(5):374-8
references.pmid: 8320430
references.citation: Clin Chem. 2007 May;53(5):911-5
references.pmid: 17363415
references.citation: Endocr Rev. 1997 Jun;18(3):404-33
references.pmid: 9183570
references.citation: Endocrinology. 2009 Mar;150(3):1097-107
references.pmid: 19179439
references.citation: Clin Chim Acta. 2004 Nov;349(1-2):181-9
references.pmid: 15469872
references.citation: Clin Endocrinol (Oxf). 1989 Nov;31(5):565-71
references.pmid: 2516787